✦ LIBER ✦

S-1-based versus 5-FU-based chemotherapy as first-line treatment in advanced gastric cancer: a meta-analysis of randomized controlled trials

✍ Scribed by Li, Dan-Hong; Pan, Zhen-Kui; Ye, Feng; An, Han-Xiang; Wu, Jing-Xun

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S-1-based therapy versus 5-FU-based ther

✍ Jiahao Huang; Yunfei Cao; Liucheng Wu; Cun Liao; Yongming He; Feng Gao 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 248 KB

6509 5-FU/l-LV (RPMI) versus S-1 as firs

✍ Sawaki, A.; Yamaguchi, K.; Nabeya, Y.; Sakai, Y.; Osanai, H.; Denda, T.; Furue, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

A meta-analysis of randomized controlled

✍ Jiang, Jingwei; Liang, Xiaohua; Zhou, Xinli; Huang, Ruofan; Chu, Zhaohui 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Overall survival benefits for irinotecan

✍ Wei-Xiang Qi; Zan Shen; Feng Lin; Yuan-Jue Sun; Da-Liu Min; Li-Na Tang; Ai-Na He 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 697 KB

Gefitinib Compared with Systemic Chemoth

✍ F. Wang; L.D. Wang; B. Li; Z.X. Sheng 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 835 KB

Meta-analysis of individual patient data

✍ Pujol, Jean-Louis; Pirker, Robert; Lynch, Thomas J.; Butts, Charles A.; Rosell, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 806 KB